Synthesis, cytotoxic and combined cDDP activity of new stable curcumin derivatives

被引:67
作者
Ferrari, Erika [1 ]
Lazzari, Sandra [1 ]
Marverti, Gaetano [2 ]
Pignedoli, Francesca [1 ]
Spagnolo, Ferdinando [1 ]
Saladini, Monica [1 ]
机构
[1] Univ Modena & Reggio Emilia, Dept Chem, I-41100 Modena, Italy
[2] Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41100 Modena, Italy
关键词
Curcuminoidic compounds; Cytotoxicity; Kinetic stability; Metal complexes; Cisplatin; Ovarian carcinoma; Vero cells; CHELATING-AGENTS; IRON CHELATION; FE-III; CELLS; DESIGN; DRUGS; ANTIBACTERIAL; SIDEROPHORE; ANTICANCER; STABILITY;
D O I
10.1016/j.bmc.2009.03.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
New curcumin derivatives are synthesized in order to improve chemical properties of curcumin. The aromatic ring glycosylation of curcumin provides more water-soluble compounds with a greater kinetic stability which is a fundamental feature for drug bioavailability. The glycosylation reaction is quite simple, low cost, with high yield and minimum waste. NMR data show that the ability of curcumin to coordinate metal ion, in particular Ga(III), is maintained in the synthesized products. Although the binding of glucose to curcumin reduces the cytotoxicity of the derivatives towards cisplatin (cDDP)-sensitive and -resistant human ovarian carcinoma cell lines, the compounds display a good selectivity since they are much less toxic against non-tumourigenic Vero cells. The combination of cDDP with the most active glycosyl-curcuminoid drug against both cDDP-sensitive and -resistant as well as against Vero cell lines is tested. The results show an improvement of cDDP efficacy with higher selectivity towards cancer cells than non-cancer cells. These studies indicate the need for developing new valid components of drug treatment protocols to cDDP-resistant cells as well. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3043 / 3052
页数:10
相关论文
共 35 条
[1]   Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents [J].
Adams, BK ;
Ferstl, EM ;
Davis, MC ;
Herold, M ;
Kurtkaya, S ;
Camalier, RF ;
Hollingshead, MG ;
Kaur, G ;
Sausville, EA ;
Rickles, FR ;
Snyder, JP ;
Liotta, DC ;
Shoji, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (14) :3871-3883
[2]   Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[3]  
ANDREWS PA, 1992, CANCER RES, V52, P1895
[4]  
[Anonymous], 2007, J. Cancer Mol.
[5]   Orthorhombic form of 6-phenylhex-5-ene-2,4-dione [J].
Arrieta, AF ;
Mostad, A .
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2001, 57 :O1198-O1199
[6]   Bacterial iron transport:: 1H NMR determination of the three-dimensional structure of the gallium complex of pyoverdin G4R, the peptidic siderophore of Pseudomonas putida G4R [J].
Atkinson, RA ;
El Din, ALMS ;
Kieffer, B ;
Lefèvre, JF ;
Abdallah, MA .
BIOCHEMISTRY, 1998, 37 (45) :15965-15973
[7]   HETEROCHROMATIN LOCATION ON CHROMOSOMES OF NORMAL AND TRANSFORMED CELLS FROM AFRICAN GREEN MONKEY (CERCOPITHECUS-AETHIOPS - DNA DENATURATION-RENATURATION METHOD [J].
BIANCHI, NO ;
AYRES, J .
EXPERIMENTAL CELL RESEARCH, 1971, 68 (02) :253-&
[8]   Curcuminoids as potential new iron-chelating agents: spectroscopic, polarographic and potentiometric study on their Fe(III) complexing ability [J].
Borsari, M ;
Ferrari, E ;
Grandi, R ;
Saladini, M .
INORGANICA CHIMICA ACTA, 2002, 328 :61-68
[9]   The role of iron chelation in cancer therapy [J].
Buss, JL ;
Torti, FM ;
Torti, SV .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (12) :1021-1034
[10]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55